|
|
1. MARKET OVERVIEW
|
Neuromodulation – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Neurological Disorders |
A Prelude to Neuromodulation |
Indications for Neuromodulation Therapy |
Impact of Covid-19 and a Looming Global Recession |
2020 Marked as a Year of Disruption & Transformation |
EXHIBIT: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022 |
Global Neuromodulation Market Buckles under COVID-19 Strain |
Effects of COVID-19 on the Nervous System Sheds Focus on Neuromodulation Applications |
GLOBAL MARKET OVERVIEW |
Neuromodulation Market Set for a Robust Growth |
Neuromodulation Market by Segment |
Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS) Represents the Largest Segments |
Neuromodulation Devices by Technology |
Spinal Cord Stimulation Market (2020): Dollar Market Share of Leading Players in Percentage |
Neuromodulation Market by Application |
Growing Clinical Applications to Drive Demand |
US and Europe Dominate the Market |
Asia-Pacific and other Emerging Regions Display Impressive Growth Potential |
Competition |
Select FDA Approved Neuromodulation Devices in Recent Years |
Recent Market Activity |
Market Restraints and Challenges |
WORLD BRANDS |
2. FOCUS ON SELECT PLAYERS
|
3. MARKET TRENDS & DRIVERS
|
High Incidence of Neurological Disorders: A Key Market Driver |
Annual Incidence of Adult-Onset Neurologic Disorders in the US |
Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders |
EXHIBIT 3: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices |
EXHIBIT 4: Global Alzheimer's Prevalence by Age Group |
EXHIBIT 5: Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries |
EXHIBIT: Global DBS Market by Leading Player (2020E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott |
Select Available Deep Brain Stimulation Devices Available in the Market |
Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices |
EXHIBIT 7: Epilepsy Incidence by Type (2019): Percentage Share Breakdown for Idiopathic and Symptomatic Epilepsy |
EXHIBIT 8: Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy |
Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices |
Recent Developments in Spinal Cord Injury Treatment |
TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth |
Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices |
Neuromodulation Technologies to Gain Preference Over Opioids |
Tibial Neuromodulation to Impact Overactive Bladder Market |
4. GLOBAL MARKET PERSPECTIVE
|
World Recent Past, Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Transcutaneous Electrical Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Repetitive Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Failed Back Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Parkinson`s Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Neuromodulation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030 |
World Recent Past, Current & Future Analysis for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030 |
|
UNITED STATES
|
Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
USA Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
CANADA
|
Canada Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
JAPAN
|
Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) |
Japan Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
CHINA
|
Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) |
China Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
China Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
China Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
EUROPE
|
Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
Europe Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
Europe Historic Review for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030 |
FRANCE
|
Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E) |
France Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
France Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
France Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
GERMANY
|
Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) |
Germany Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
ITALY
|
Italy Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
UNITED KINGDOM
|
Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) |
UK Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
REST OF EUROPE
|
Rest of Europe Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
ASIA-PACIFIC
|
Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
REST OF WORLD
|
Rest of World Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030 |
|
|